12
Total investments
0
Early stage
9
Mid stage
3
Late stage
3y
Years active
Portfolio
12 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investisseur
Jul 2025
One Biosciences leverages the power of single-cell analysis to unlock a new wave of targets and precision medicines for a broad range of difficult-to-treat conditions. One Biosciences is an integrated discovery engine combining a multi-disciplinary team with in-house computational capabilities. One Biosciences is backed by Institut Curie and Home Biosciences.
Investisseur
Dec 2024
Biomemory is a deep-tech company specialized in enterprise data storage. It leverages molecular engineering to build cost-effective and energy-efficient exabyte rackable appliances for Data Centers.
Biomemory also develops high-quality DNA-based anti-counterfeiting systems with minimal ecological impact.
Contact us: contact@biomemory.com
Jobs and internships: jobs@biomemory.com
Investisseur
Dec 2024
Tomorrow.bio is advancing biostasis by providing high-quality cryopreservation services in the heart of Europe.
As the world’s fastest-growing cryopreservation company with 800+ members, our mission is simple: to enable people to choose how long they want to live.
Were optimistic about the future, the power of technology, and—above all—life itself. Our international team of doctors, engineers, and entrepreneurs is young, driven, and committed to making medical time travel a reality.
With a pricing model designed for transparency, flexibility, and long-term value, we’re making cryopreservation more accessible than ever.
Join us—and get ready for tomorrow 💙
https://member.tomorrow.bio/signup/start
Investisseur
Oct 2024
Order fast 7/7 for express delivery in Paris region and D+1 everywhere else in France.
Incredible choice of products. Ultimate delivery experience.
www.labellevie.com
Promo code : paullbv (5 euros offered, first order only)
Test it. Love it.
#foodtech #retailtech #darkgrocery
Investisseur
Sep 2024
Mindstate Design Labs is a clinical-stage AI neuroengineering platform. Were making every therapeutically valuable emotion available on demand in pharmaceutical form.
Our Osmanthus platform is an ensemble of AI models that synthesize the world’s largest datasets of psychoactive pharmacology and phenomenology, quantitatively pinpointing the combination of neurotransmitter receptor activity that underlies various emotional as well as cognitive and perceptual states.
Our lead program MSD-001 is designed to be rapid-acting and produce heightened emotional and cognitive flexibility (without hallucinations). MSD-001 is currently in human trials, and will be the base ingredient for multiple drug combination "emotions in a bottle" such as empathy, awe, clarity, or beauty.
Investisseur
Jun 2024
Yumgo cest la première vraie solution végétale, pour remplacer les œufs dans les recettes. Créé par un chef et pour les chefs. Pour un résultat inratable, gourmand et de qualité 🌱
Des produits imaginés pour répondre aux enjeux des professionnels de la gastronomie, et faciliter la transition des chefs vers le végétal: une utilisation simple (identique aux œufs), un résultat savoureux, beau, éthique, fiable et de qualité.
Investisseur
Feb 2024
Leader en France des paniers de fruits et légumes anti gaspi
Plus de 50 tonnes de légumes sauvés chaque jour
Déjà 1 million de paniers sauvés en à peine 18 mois
+ de 300 millions de vue sur lapplication anti gaspi too good to go !
Investisseur
Jan 2024
Latitude is a pioneering French rocket launch company on a mission to push the boundaries of space technologies, fostering a better and brighter future for all. With our 20m height Zephyr launcher, we strive to create innovative and sustainable solutions for space exploration and development, while placing human experiences at the core of our journey.
Our team is driven by the values of optimism, innovation, collaboration, perseverance, and boldness. At Latitude, we believe in the power space exploration and the limitless possibilities it offers. Were not just launching rockets; were launching dreams and building the foundation for a more resilient and inspired world.
As we embark on this cosmic adventure, our warm and authentic approach brings a sense of belonging and togetherness, making space more accessible and inviting for you. Our motto, "Bienvenue in your space," reflects our commitment to creating a more inclusive and diverse space community.
Join us at Latitude and be part of our dynamic, collaborative team that is redefining the future of space exploration. Lets shape the cosmos together, one launch at a time.
Explore career opportunities at latitude.eu/jobs and be part of our cosmic journey.
Investisseur
Sep 2023
Wheere is a French deeptech company revolutionizing indoor geolocation.
Our technology is the only one capable of covering a site of one square kilometer with just four transmitters.
By leveraging unmodulated low-frequency waves and a unique algorithm, our solution penetrates even the densest obstacles, such as concrete walls, and offers a sub-meter accuracy.
Founded in 2021 by Pierre-Arnaud Coquelin and Antoine Carrabin, Wheere successfully closed an €11 million seed round in July 2023.
At Wheere, our mission is to make indoor geolocation as accessible as GPS—ubiquitous, affordable, and integrated into all B2C and B2B devices.
To achieve this, we have two key milestones ahead:
- By 2027: Reduce the size, energy consumption, and production costs of our receivers.
- By 2030: Achieve global availability of our technology through the spatial deployment of our #LEOPNT transmitters.
Investisseur
Jun 2023
Aujourd’hui, 25% de lempreinte carbone mondiale provient des échanges internationaux : ils génèrent énormément d’émissions pour trop peu d’actions mises en place.
Keewe, c’est la fintech pour des échanges internationaux plus simples et plus durables. On pense que l’action écologique ne doit pas être un coût à subir mais un avantage compétitif pour embarquer les entreprises.
On agit sur
- l’impact : on mesure l’empreinte carbone des opérations tout en générant de l’impact positif
- le prix : on est ultra compétitifs et transparents par rapport au marché bancaire et aux autres fintech
- la simplicité : c’est facile, intuitif. Tous les services financiers internationaux sont au même endroit.
Pour convaincre, on doit simplifier. L’impact ne doit pas être une charge supplémentaire. Les entreprises n’ont rien à faire: on est là pour accompagner.
____________________________________________________________________________
Lauréat de Scale up Excellence de la French Tech
Prix coup de ❤ du Challenge Fintech for Tomorrow 2019
Labellisé Envol! : https://www.envol-entreprise.fr/
Et accéléré par WILCO (https://www.wilco-startup.com/)
www.keewe.eu
Investisseur
Feb 2023
Référencez votre marque sur lapplication HEMBLEM pour booster votre visibilité sur les réseaux sociaux et attirer une nouvelle clientèle grâce au marketing dinfluence !
Grâce à notre plateforme révolutionnaire, obtenez tous les mois des collaborations non rémunérées avec des influenceurs vérifiés. En échange dexpériences ou de produits offerts, notre réseau de blogueurs publieront du contenu sur votre marque auprès de leurs larges communautés (de 10K followers à plusieurs millions).
Avec plus de 4 000 influenceurs lifestyle qualifiés, HEMBLEM est la plateforme numéro 1 en France pour vous gérer des centaines de collaborations en quelques clics.
Investisseur
Feb 2023
At Ulysse, we are a team of travelers and we know how stressful travelling can sometimes be. Because of this, we place ourselves on the side of the traveler in order to make sure that you have the best experience possible. Transparency, sympathy and benevolence: the three qualities that we bring to the table.
Experience · 12 entries
All (12)
Investments (12)
2025
Investisseur
Jul 2025
One Biosciences leverages the power of single-cell analysis to unlock a new wave of targets and precision medicines for a broad range of difficult-to-treat conditions. One Biosciences is an integrated discovery engine combining a multi-disciplinary team with in-house computational capabilities. One Biosciences is backed by Institut Curie and Home Biosciences.
2024
Investisseur
Dec 2024
Biomemory is a deep-tech company specialized in enterprise data storage. It leverages molecular engineering to build cost-effective and energy-efficient exabyte rackable appliances for Data Centers.
Biomemory also develops high-quality DNA-based anti-counterfeiting systems with minimal ecological impact.
Contact us: contact@biomemory.com
Jobs and internships: jobs@biomemory.com
Investisseur
Dec 2024
Tomorrow.bio is advancing biostasis by providing high-quality cryopreservation services in the heart of Europe.
As the world’s fastest-growing cryopreservation company with 800+ members, our mission is simple: to enable people to choose how long they want to live.
Were optimistic about the future, the power of technology, and—above all—life itself. Our international team of doctors, engineers, and entrepreneurs is young, driven, and committed to making medical time travel a reality.
With a pricing model designed for transparency, flexibility, and long-term value, we’re making cryopreservation more accessible than ever.
Join us—and get ready for tomorrow 💙
https://member.tomorrow.bio/signup/start
Investisseur
Oct 2024
Order fast 7/7 for express delivery in Paris region and D+1 everywhere else in France.
Incredible choice of products. Ultimate delivery experience.
www.labellevie.com
Promo code : paullbv (5 euros offered, first order only)
Test it. Love it.
#foodtech #retailtech #darkgrocery
Investisseur
Sep 2024
Mindstate Design Labs is a clinical-stage AI neuroengineering platform. Were making every therapeutically valuable emotion available on demand in pharmaceutical form.
Our Osmanthus platform is an ensemble of AI models that synthesize the world’s largest datasets of psychoactive pharmacology and phenomenology, quantitatively pinpointing the combination of neurotransmitter receptor activity that underlies various emotional as well as cognitive and perceptual states.
Our lead program MSD-001 is designed to be rapid-acting and produce heightened emotional and cognitive flexibility (without hallucinations). MSD-001 is currently in human trials, and will be the base ingredient for multiple drug combination "emotions in a bottle" such as empathy, awe, clarity, or beauty.
Show all 12 entries ↓
Investment activity
2023–2025 · 12 investments
Recent (last 2 years)Earlier
